Physician profile
Behnam Manesh
NPI 1295811487
$3,943.69
in general payments reported to CMS, 2019-2025
13 companies · $729 in 2025
The $729 reported for 2025 was more than what 93% of Dentist providers received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,197 · 2020: $492 · 2021: $225 · 2022: $720 · 2023: $103 · 2024: $478 · 2025: $729.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,208 · Consulting Fee: $102.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,208.32 |
| Consulting Fee | $101.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $3,444.06 | 2019-2025 | Invisalign, Invisalign Lens, Assembly Kit |
| Zest Holdings, LLC | $91.45 | 2025 | |
| Orapharma, A Division of Bausch Health US, LLC | $69.83 | 2023-2024 | Arestin, Ossix Plus |
| Solventum Corporation | $65.30 | 2025 | 3m Espe Filtek Supreme Ultra Universal Restorative, Relyx Unicem Aplicap, 3m Clinpro |
| Patterson Companies, INC. | $59.65 | 2021 | |
| Dentsply Sirona INC | $45.49 | 2019-2021 | |
| Henry Schein, INC. | $38.93 | 2023 | |
| 3m Company | $36.75 | 2019-2021 | |
| Zimvie INC. | $28.07 | 2022 | |
| Philips North America LLC | $16.89 | 2025 | Power Toothbrush Undivided |
| Envista Holdings Corporation | $16.52 | 2024 | Optibond Solo Plus |
| Biohorizons Implant Systems INC. | $15.50 | 2025 | Biohorizons Dental Implants |
| Kerr Corporation | $15.25 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Behnam Manesh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.